Starting August 1st, EndoPredict®, a genomic test for breast cancer patients, and Prolaris® Kits, a prognostic test for prostate cancer patients, are joining the Eurobio Scientific portfolio. As a leading player in Molecular Diagnostics and Life Sciences, we are thrilled to expand our offer and enhance our commitment to innovative patient care.